Brain imaging and cognitive dysfunctions in Huntington's disease - Test2 - elhamkhani - TriplyDB

Brain imaging and cognitive dysfunctions in Huntington's disease

Brain imaging and cognitive dysfunctions in Huntington's disease

http://www.wikidata.org/entity/Q24535934

about

Cognitive Training at a Young Age Attenuates Deficits in the zQ175 Mouse Model of HD.Genistein improves 3-NPA-induced memory impairment in ovariectomized rats: impact of its antioxidant, anti-inflammatory and acetylcholinesterase modulatory properties.The involvement of secondary neuronal damage in the development of neuropsychiatric disorders following brain insults.Zebrafish: An in vivo model for the study of neurological diseases.Cognitive reserve and brain reserve in prodromal Huntington's disease.Studies on the Q175 Knock-in Model of Huntington's Disease Using Functional Imaging in Awake Mice: Evidence of Olfactory Dysfunction Conditional targeting of medium spiny neurons in the striatal matrix.Magnetic resonance imaging of Huntington's disease: preparing for clinical trials.QEEG Measures in Huntington's Disease: A Pilot Study.Motor-Language Coupling in Huntington's Disease Families.Association between Age and Striatal Volume Stratified by CAG Repeat Length in Prodromal Huntington Disease.Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission Interpretive monitoring in the caudate nucleus.Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.Type 2 transglutaminase in Huntington's disease: a double-edged sword with clinical potential.Reduced expression of conditioned fear in the R6/2 mouse model of Huntington's disease is related to abnormal activity in prelimbic cortex.Differential Changes in Postsynaptic Density Proteins in Postmortem Huntington's Disease and Parkinson's Disease Human Brains.Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.Mitochondria as a therapeutic target for aging and neurodegenerative diseases.Influence of intensive multifunctional neurorehabilitation on neuronal oxidative damage in patients with Huntington's disease Dynamin-related protein 1 heterozygote knockout mice do not have synaptic and mitochondrial deficiencies The BACHD Rat Model of Huntington Disease Shows Signs of Fronto-Striatal Dysfunction in Two Operant Conditioning Tests of Short-Term Memory.Cognitive impairment in Huntington disease: diagnosis and treatment.Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease.Varenicline improves motor and cognitive symptoms in early Huntington's disease.Mitochondrial structural and functional dynamics in Huntington's disease.Brain networks in Huntington disease.Strategies for regenerating striatal neurons in the adult brain by using endogenous neural stem cells Acetylcholinesterase inhibitors in cognitive impairment in Huntington's disease: A brief review.Enhanced expression of three monocarboxylate transporter isoforms in the brain of obese mice.Non-Verbal and Verbal Fluency in Prodromal Huntington's Disease.Graph analysis of epileptogenic networks in human partial epilepsy.Robust sequential working memory recall in heterogeneous cognitive networks.Modulation at age of onset in tunisian huntington disease patients: implication of new modifier genes Wanted dead or alive? The tradeoff between in-vivo versus ex-vivo MR brain imaging in the mouse.The transcriptional response of skin to fluorescent light exposure in viviparous (Xiphophorus) and oviparous (Danio, Oryzias) fishes.The many facets of unawareness in huntington disease.Early Alterations in Operant Performance and Prominent Huntingtin Aggregation in a Congenic F344 Rat Line of the Classical CAGn51trunc Model of Huntington Disease.Therapy development in Huntington disease: From current strategies to emerging opportunities.

P2860

Q27321673-C193BE47-2164-4333-AA7A-794B584952B2 Q30418168-53401F76-075D-4641-A300-133D9530049B Q30441452-8176AF59-1E40-42BB-830B-27FBE6E8A83B Q30493208-54BAF5F4-0038-4A3A-867C-2513393244FC Q30541757-0D91E1AD-FD6F-4E5B-A32C-14889B8D1D91 Q30581974-64F7909A-697F-4A9A-9BC2-FCE6BE5E5440 Q30632650-B45E94CA-9D71-42A9-ACA7-1E7B8080CE26 Q33437923-D652051E-2053-4E70-ACAB-B8D87F2C7705 Q33734662-67C4F6B9-504E-4A72-8442-E42F5D1802DA Q33743709-3050C664-90D4-4F92-9230-19244B9DA335 Q33905387-C2F42089-1A48-4B06-950E-1BBA4DE1BE5E Q34313991-8B481934-5B2F-4B42-9A96-F2ECD2B74B55 Q34545833-2FF652E1-9EAD-4A12-918C-DEB23608F82F Q34627072-5E1C8622-2777-4816-A672-EACDB67404AA Q34775357-AF0DAC2D-4A06-44C6-B112-33D9048A71AD Q35042882-06CEC6EA-13E0-4A46-9C5E-879B2908D5D3 Q35623502-02213F76-3FBF-4CD3-BE1A-947BD09FE649 Q35645271-812CF1E1-72A4-4AF2-BB6A-9BC229514B67 Q35747131-3B2B331F-C8B3-4911-8B67-98640C36C51D Q35807409-2AC958D4-A548-4D7F-8EA9-283EAED81DEC Q35904286-78B5E075-8E77-423C-BA5B-DFBD0FFAE64D Q35918643-D2358F32-0EA5-49F9-8117-CBA6A5B4574B Q36238024-E31690A7-F689-49B6-AC6A-10C0DF93831C Q36773397-B395927C-B8D6-44C6-9D6D-66AF3F4C6D08 Q37178581-DECE06E7-316F-49C4-8A19-4A1F119F4FAC Q37279618-C3C679DC-F435-4BC8-86D1-5D37835A9AE8 Q37356257-BF8EA539-8530-4C2F-9FCB-5D203AEFFBCD Q37834193-EF28A72B-E02D-4C5F-BAA6-548DE9269968 Q37902080-CD8884EB-B7DE-4FD0-B5DB-97625C8BCFA5 Q38164337-365F1BA4-CC66-4E3D-91EE-3D75CDC40D1C Q38300423-A24A2D5F-F8DD-4B62-9203-A77F63CE0247 Q38395042-F0731E84-3F3A-4E0E-A23E-4964DC1CD23D Q38805555-727246FB-CF3E-43E2-8177-43FFDF0B8E59 Q41978023-C33C86ED-780E-4ACA-B90D-23C43A2C1041 Q42151377-0F963A66-85A4-42E3-A40B-925821C789EE Q42224781-A1168DE8-E113-4BF5-B5DF-ABFCC684A0A4 Q42778078-5100C300-D48B-473A-97CD-F67E14BED380 Q43004947-C5DB22C2-A376-4CE8-BEA8-9DA3C629237D Q49560971-A0D296DA-7F30-4256-82D4-5BE06FB6085C Q53716390-DA531B70-3C75-45B6-A245-EBA89EED8AC8

P2860

Brain imaging and cognitive dysfunctions in Huntington's disease

http://www.wikidata.org/entity/Q24535934

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Brain imaging and cognitive dysfunctions in Huntington's disease

@ast

Brain imaging and cognitive dysfunctions in Huntington's disease

@en

Brain imaging and cognitive dysfunctions in Huntington's disease

@en-gb

Brain imaging and cognitive dysfunctions in Huntington's disease

@nl

type

label

Brain imaging and cognitive dysfunctions in Huntington's disease

@ast

Brain imaging and cognitive dysfunctions in Huntington's disease

@en

Brain imaging and cognitive dysfunctions in Huntington's disease

@en-gb

Brain imaging and cognitive dysfunctions in Huntington's disease

@nl

prefLabel

Brain imaging and cognitive dysfunctions in Huntington's disease

@ast

Brain imaging and cognitive dysfunctions in Huntington's disease

@en

Brain imaging and cognitive dysfunctions in Huntington's disease

@en-gb

Brain imaging and cognitive dysfunctions in Huntington's disease

@nl

P1433

Q24535934-01A4710C-BEEC-4E11-AD47-23D7C4641F6D

P1476

Q24535934-B1064F85-F11A-43BE-B7B9-0B454A8FB32F

P2093

Q24535934-107D0F70-23BE-4781-96D3-D50F3B52F7ED

Q24535934-3DECA5C5-92A3-4DE4-B568-549DBEBC7FE6

Q24535934-7EA29F88-6C1C-4EFA-9EB6-B2188E782546

Q24535934-BC73638E-BD73-4A89-B793-43F792F9ECBF

P2860

Q24535934-00593CF2-80CA-435B-9DEA-BA3CA70A43CE

Q24535934-04677E23-2A91-411B-B1FB-98F509AFAB70

Q24535934-07B9AA38-FDFC-4F6F-9B44-B989DEC4E51A

Q24535934-08A07308-CDC9-4BA4-9477-6599AC9433F5

Q24535934-0BD5BFC4-45CD-41DF-8067-182187F595E0

Q24535934-0C046E70-6C10-43E3-A02C-8CE25E04234F

Q24535934-0CF0338F-16D6-4850-8BF4-233B5E303B42

Q24535934-0E30B3DC-1304-4D1A-A5B4-195A2B41D0F2

Q24535934-11B921D3-C201-423D-BBCC-361ABB4974B9

Q24535934-145F4F7B-572B-411D-9365-50368FF48E5E

P304

Q24535934-8400138F-D6C1-4F4B-ACF0-2199305C97E1

P31

Q24535934-975B959D-D607-4792-92F4-8D0CDFD5FDAA

P3181

Q24535934-389D5E7C-E5FE-49F0-BAE4-5FDED7DFDD3A

P407

Q24535934-1B6203A4-50FF-45E0-A685-045CE7F3D55A

P433

Q24535934-10697125-C7C2-4FAA-A91F-B7FA5BFFCDD4

P478

Q24535934-3FED9AF7-081F-4A0A-A0A5-3C171032BEE2

P577

Q24535934-3EAF1054-A2DD-4A73-BE63-ED1C8743D126

P698

Q24535934-A4F0DD91-A30E-4F83-94F8-BE4A10BC933B

P921

Q24535934-5EF42D11-3035-4BD6-AF65-45F992FEC56A

Q24535934-75A6CD33-33FA-489C-962E-06C0182E6445

P932

Q24535934-B72874A7-3163-4729-9820-E8523DD99F40

P3181

P1433

Journal of Psychiatry & Neuroscience

P1476

Brain imaging and cognitive dysfunctions in Huntington's disease

@en

P2093

Alonso Montoya

http://www.w3.org/2001/XMLSchema#string

Bruce H Price

http://www.w3.org/2001/XMLSchema#string

Martin Lepage

http://www.w3.org/2001/XMLSchema#string

Matthew Menear

http://www.w3.org/2001/XMLSchema#string

P2860

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans

Neurovascular regulation in the normal brain and in Alzheimer's disease

Clinical correlation of striatal 1H MRS changes in Huntington's disease.

[Cognitive deterioration in Huntington disease]

Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET.

Imaging cognition II: An empirical review of 275 PET and fMRI studies.

Reduced regional cerebral blood flow in Huntington's disease studied by SPECT.

Prefrontal cortical blood flow and cognitive function in Huntington's disease.

Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia.

P304

21-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3463239

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16496032

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

1325063

http://www.w3.org/2001/XMLSchema#string